Skip to content

CID SpA

Active in EUDAMED

Italyfrom SRN EUDAMED SRN IT-MF-000032616

Devices
459
Registrations
EUDAMED

Catalogue459

Newest first, rows 451-459 of 459

Search and filter all 459 devices

  • ICLK2516

    Active Regimes: CE MDD Registry: EUDAMED Class:III

  • ICLK4520

    Active Regimes: CE MDD Registry: EUDAMED Class:III

  • ICLK3031

    Active Regimes: CE MDD Registry: EUDAMED Class:III

  • ICLK2546

    Active Regimes: CE MDD Registry: EUDAMED Class:III

  • ICLK3025

    Active Regimes: CE MDD Registry: EUDAMED Class:III

  • ICLK27525

    Active Regimes: CE MDD Registry: EUDAMED Class:III

  • ICLK3516

    Active Regimes: CE MDD Registry: EUDAMED Class:III

  • ICLK22525

    Active Regimes: CE MDD Registry: EUDAMED Class:III

  • ICLK4020

    Active Regimes: CE MDD Registry: EUDAMED Class:III

Showing 451-459 of 459

Company details

EUDAMED SRN
IT-MF-000032616
EU VAT number
06356990967
EUDAMED status
Active
EUDAMED registered name
CID Spa
EUDAMED abbreviated name
CID
Registered address
218, viale Certosa, 20156, Milano, Italy
Phone
+39 3405805403
PRRC contact
Vittoria Allono(public in EUDAMED)

From the company website

Read 18 Oct 2026

During the LBT session at CRT2026, the 5 year results of the independent SUGAR RCT in diabetic patients have shown that the superior TLF outcome at 1 year of the CID Cre EVO™ DES vs. Onyx™ DES has been maintained at 5 years (TLF at 1 year: 7.2% Cre8 EVO™ vs. 10.9% Onyx™; p superiority = 0.030. TLF from 1 to 5 years: 6.4% Cre8 EVO™ vs. 6.5% Onyx™)

From the manufacturer's own website. Source